<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05006027</url>
  </required_header>
  <id_info>
    <org_study_id>9-2021-0031</org_study_id>
    <nct_id>NCT05006027</nct_id>
  </id_info>
  <brief_title>Feasibility of PCI Using a 7-Fr Thin-Wall Sheath Via the DRA</brief_title>
  <acronym>SEVEN-BOX</acronym>
  <official_title>Feasibility of Percutaneous Coronary Intervention Using a 7-Fr Thin Wall Sheath Via the Snuffbox Approach: a Prospective Observational Study (SEVEN-BOX)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yongin Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Merit Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of percutaneous coronary intervention using a&#xD;
      7-French(Fr) thin wall sheath via the snuffbox approach&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, coronary angiography (CAG) and percutaneous coronary intervention (PCI) via the&#xD;
      distal radial artery access (DRA), also known as the snuffbox approach, have shown several&#xD;
      advantages owing to fewer complications, such as radial artery occlusion, pseudoaneurysms,&#xD;
      and arteriovenous(AV) fistulas, and short hemostasis duration than the proximal radial access&#xD;
      (PRA). However, despite the potential advantages of the DRA, there are still many&#xD;
      cardiologists who prefer the femoral approach for complex PCI including left main disease,&#xD;
      bifurcation lesions, heavily calcified lesions, which need a strong backup and using several&#xD;
      devices. The radial artery and the distal radial artery have a smaller diameter than the&#xD;
      femoral artery, and interventional cardiologists are usually performed using the 6-Fr sheath.&#xD;
      The previously developed 7-Fr sheath has a higher risk of vascular occlusion when use in a&#xD;
      radial artery due to larger diameter compared to radial artery in 30% to 60% of patients.&#xD;
      However, with the recent development of various technologies, the outer diameter of the&#xD;
      sheath is gradually becoming thinner and recently a 7-Fr slender sheath which does not differ&#xD;
      significantly from the outer diameter of the 6-Fr sheath used in the previously PRA&#xD;
      demonstrated that feasibility and safety for radial artery intervention. Despite the&#xD;
      feasibility and potential benefits of the DRA and 7-Fr thin wall sheath for radial artery,&#xD;
      there is a lack of data regarding the safety and efficacy of a 7-Fr thin-wall sheath during&#xD;
      the DRA.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 16, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Access site complication during hospitalization and within 1-month follow-up</measure>
    <time_frame>Through procedure completion, up to 1month</time_frame>
    <description>bleeding(defined by BARC criteria), hematoma (hand hematoma[&lt;5cm, 5-10cm,&gt;10cm[ and forearm hematoma), numbness, AV fistula, Pseudoaneurysm, and artery occlusion (conventional and distal radial artery) by ultrasonography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate of PCI</measure>
    <time_frame>Through procedure completion, up to 1month</time_frame>
    <description>Success rate of PCI using 7-Fr sheath via the snuffbox approach (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemostasis duration</measure>
    <time_frame>Through procedure completion, up to 24 hours</time_frame>
    <description>Hemostasis duration using 7-Fr sheath via the snuffbox approach (minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patency of proximal radial artery after hemostasis</measure>
    <time_frame>Through procedure completion, up to 24 hours</time_frame>
    <description>Patency of proximal radial artery using 7-Fr sheath via the snuffbox approach by ultrasonography after hemostasis (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patency of distal radial artery after 1 month</measure>
    <time_frame>Time Frame: up to 1month</time_frame>
    <description>Patency of distal radial artery using 7-Fr sheath via the snuffbox approach by ultrasonography after 1-month (%)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Distal Radial Artery</condition>
  <condition>Complex Intervention</condition>
  <arm_group>
    <arm_group_label>Percutaneous coronary intervention using a 7-Fr thin wall sheath via the snuffbox approach</arm_group_label>
    <description>patients with coronary artery disease who planned to perform PCI using 7-Fr thin wall sheath via the snuffbox approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention via the snuffbox approach</intervention_name>
    <description>Percutaneous coronary intervention using a 7-Fr thin wall sheath (Prelude IDeal, MERIT MEDICAL, South Jordan, UT, USA) via the snuffbox approach</description>
    <arm_group_label>Percutaneous coronary intervention using a 7-Fr thin wall sheath via the snuffbox approach</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with coronary artery disease who planned to perform PCI using a 7-Fr thin wall&#xD;
        sheath will be recruited&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients, â‰¥ 20 years of age, who were diagnosed with ischemic heart disease requiring&#xD;
             percutaneous coronary intervention (PCI)&#xD;
&#xD;
          -  Patients who are palpable distal radial artery&#xD;
&#xD;
          -  The decision to participate voluntarily in this study and the written consent of the&#xD;
             patient&#xD;
&#xD;
          -  Patients who planned to perform PCI using a 7-Fr thin wall sheath&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are not palpable distal radial artery&#xD;
&#xD;
          -  Female of childbearing potential, who possibly plans to become pregnant any time after&#xD;
             enrollment into this study&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patients who are not appropriate for this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Yongcheol Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yongin Severance Hopistal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yongcheol Kim, MD</last_name>
    <phone>+82-031-5189-8967</phone>
    <email>yongcheol@yuhs.ac</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ji Woong Roh, MD, PhD</last_name>
    <phone>+82-031-5189-8792</phone>
    <email>NOMGALDA@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yongin Severance Hospital</name>
      <address>
        <city>Yongin</city>
        <state>Gyeonggi-do</state>
        <zip>16995</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Miju Shin</last_name>
      <phone>+82-031-5189-8893</phone>
      <email>mijushin@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>Yongcheol Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oh-Hyun Lee</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ji Woong Roh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eui Im</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deok-Kyu Cho</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donghoon Choi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yongin Severance Hospital</name>
      <address>
        <city>Yongin</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongcheol Kim, MD</last_name>
      <email>YONGCHEOL@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 8, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yonsei University</investigator_affiliation>
    <investigator_full_name>Yongcheol Kim</investigator_full_name>
    <investigator_title>Director head of snuffbox center in Yongin Severance Hospital, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>distal radial artery</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No planned</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

